Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Solid Tumor × roniciclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

vistusertib 2 toripalimab 1 tanespimycin 1 sargramostim 1 roniciclib 1 abemaciclib 1 Letrozole 1 Ipilimumab 1 Hydroxychloroquine 1 Fulvestrant 1 Anastrozole 1 Albumin-Bound Paclitaxel 1 AMG 337 1 4-toluenesulfonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02656849 2016-07-01

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

Dana-Farber Cancer Institute

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡